Progestérone et transfert d’embryon congelé préparé par traitement hormonal substitutif : état des lieux des pratiques
Autor: | I. Cédrin-Durnerin, M. Commissaire, M. Peigné |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Gynecology medicine.medical_specialty What treatment 030219 obstetrics & reproductive medicine Dose business.industry Early Pregnancy Loss media_common.quotation_subject Obstetrics and Gynecology Fertility medicine.disease Embryo transfer Miscarriage 03 medical and health sciences Route of administration 030104 developmental biology 0302 clinical medicine Reproductive Medicine medicine Medical prescription business media_common |
Zdroj: | Gynécologie Obstétrique Fertilité & Sénologie. 48:196-203 |
ISSN: | 2468-7189 |
DOI: | 10.1016/j.gofs.2019.11.003 |
Popis: | Frozen-thawed embryo transfer (FET) has recently become the most frequently performed ART procedure. Many protocols for endometrial preparation are used, without any evidence-based superiority of one protocol above the others. Most French fertility centers mainly use hormonal replacement treatment (HRT) for endometrial preparation for organizational reasons. According to some studies, early pregnancy losses rate is higher with HRT endometrial preparation for FET than with other protocols, leading to new insights in improving outcomes into ART centers. There is a lack of consensual guidelines regarding the use of HRT for FET: there are various protocols, with different dosages, duration and routes for progesterone (PG) prescription. To date, the vaginal route is the most popular around the world as it gives higher intra-uterine concentration of PG because of the first uterine pass. However, recent scientific publications have pointed the importance of PG measurement in order to detect a lack of PG supplementation. Whatever the route of administration, it seems that a significant proportion of patients do not reach adequate PG concentrations for successful implantation and ongoing pregnancy. Timing of the measurement and ideal serum PG rate to reach are yet to be defined. What treatment strategy to adopt according to the results is still under investigation. Individualization of PG doses and routes of administration could lead to a decrease in miscarriages and better outcome. |
Databáze: | OpenAIRE |
Externí odkaz: |